QUEST Clinical Trial Summary
The QUEST study is for men with metastatic prostate cancer (which means that cancer has spread to other parts of the body such as bones, liver or lung), who have already received androgen receptor (AR)-targeted therapy, but the cancer has still progressed.
WHY IS THIS CLINICAL RESEARCH STUDY BEING DONE? The objective of the study is to look at different combinations of an investigational drug in combination with other investigational anticancer drugs, to see whether they are safe and effective (how well something works) for the treatment of prostate cancer.
WHAT TREATMENT WILL I RECEIVE? If you are eligible, you will receive the investigational medication in combination with another investigational anticancer drug. The combination assigned to you will depend on the eligibility criteria you meet, your prior treatments and the characteristics of your tumor.
AM I ELIGIBLE? You may be eligible to participate in this study if you:
INTERESTED IN PARTICIPATING?
To learn more about this study and to find out if you may be eligible and if the study is being conducted at a site near you, please visit: https://clinicaltrials.gov/ct2/show/NCT03431350
PHEN Contact: 617-481-4020 option 3 for Dr. Keith Crawford
Please Note: This information is provided for education and awareness purposes. A decision on clinical trials participation is to be made between the patient and his doctor.